Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An open label clinical trial of ibezapolstat in patients with multiply-recurrent C. difficile infection, evaluating its efficacy as a single agent for treatment and prevention

Next Previous
Trial Profile

An open label clinical trial of ibezapolstat in patients with multiply-recurrent C. difficile infection, evaluating its efficacy as a single agent for treatment and prevention

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 17 Mar 2026

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ibezapolstat (Primary)
  • Indications Clostridium difficile infections
  • Focus Therapeutic Use

Most Recent Events

  • 17 Mar 2026 New trial record
  • 09 Mar 2026 According to an Acurx media release, trial start-up activities for this new clinical trial in rCDI will initiate later this month with the first patient expected to enroll in the fourth quarter this year. This will inform elements of a planned active-controlled, Phase 3 registration trial in the rCDI indication to be implemented following favorable results from the open-label 20 patient trial.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top